Dopamine, GABA, cholecystokinin and opioids in neuroleptic-induced tardive dyskinesia (Q39472252)

12 September 2017

1 reference

title

Dopamine, GABA, cholecystokinin and opioids in neuroleptic-induced tardive dyskinesia (English)

1 reference

12 September 2017

1 reference

1 reference

Ebadi M

1

1 reference

12 September 2017

Hama Y

series ordinal

2

1 reference

12 September 2017

publication date

1 September 1988

1 reference

Neuroscience & Biobehavioral Reviews

12 September 2017

published in

1 reference

12 September 2017

volume

12

1 reference

12 September 2017

issue

3-4

1 reference

12 September 2017

page(s)

179-187

1 reference

Neuroleptic malignant syndrome: review and analysis of 115 cases

12 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2888%2980039-3

7 January 2021

Extrapyramidal reactions with metoclopramide

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2888%2980039-3

7 January 2021

The distribution of cholecystokinin immunoreactivity in the central nervous system of the rat as determined by radioimmunoassay

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2888%2980039-3

7 January 2021

Stimulation of Dopamine Synthesis in Caudate Nucleus by Intrastriatal Enkephalins and Antagonism by Naloxone

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2888%2980039-3

7 January 2021

Reduced glutamic-acid-decarboxylase activity of post-mortem brain in Huntington's chorea

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2888%2980039-3

7 January 2021

Tetrabenacine treatment in persisting dyskinesia caused by psychopharmaca.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2888%2980039-3

7 January 2021

Neuroleptic Malignant syndrome caused by dopamine-depleting drugs in a patient with Huntington disease

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2888%2980039-3

7 January 2021

Neuroleptic-Induced Dyskinesias in Children

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2888%2980039-3

7 January 2021

EFFECT OF CHLORPROMAZINE OR HALOPERIDOL ON FORMATION OF 3METHOXYTYRAMINE AND NORMETANEPHRINE IN MOUSE BRAIN.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2888%2980039-3

7 January 2021

Neuroleptic malignant syndrome and malignant hyperthermia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2888%2980039-3

7 January 2021

Anticonvulsant-induced dyskinesias: a comparison with dyskinesias induced by neuroleptics

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2888%2980039-3

7 January 2021

Increase in brain 125I-cholecystokinin (CCK) receptor binding following chronic haloperidol treatment, intracisternal 6-hydroxydopamine or ventral tegmental lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2888%2980039-3

7 January 2021

Decreased antistereotypic effect of neuroleptics after additional treatment with a benzodiazepine, a GABA agonist or an anticholinergic compound

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2888%2980039-3

7 January 2021

Dyskinesias associated with lithium therapy in parkinsonism.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2888%2980039-3

7 January 2021

Dopamine receptors in the central thermoregulatory pathways of the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2888%2980039-3

7 January 2021

Do central dopamine receptors have a physiological role in thermoregulation?

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2888%2980039-3

7 January 2021

Research in Endorphins and Schizophrenia*

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2888%2980039-3

7 January 2021

Dopamine receptor elevation by cholecystokinin

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2888%2980039-3

7 January 2021

Chloral hydrate and warfarin

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2888%2980039-3

7 January 2021

Dyskinesias Associated with Tricyclic Antidepressants

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2888%2980039-3

7 January 2021

NEUROLOGICAL SYMPTOMS IN PHARMACOTHERAPY OF PSYCHOSES

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2888%2980039-3

7 January 2021

Hyperthermia after discontinuance of levodopa and bromocriptine therapy: impaired dopamine receptors a possible cause

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2888%2980039-3

7 January 2021

Cholecystokinin octapeptide levels in rat brain are changed after subchronic neuroleptic treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2888%2980039-3

7 January 2021

Evidence for underactivity of the opioid system in neuroleptic-induced akathisia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2888%2980039-3

7 January 2021

Differential diagnosis of tardive dyskinesia: an overview

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2888%2980039-3

7 January 2021

Neuroleptic malignant syndrome: successful treatment with dantrolene and bromocriptine

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2888%2980039-3

7 January 2021

The neuroleptic malignant syndrome: review and report of three cases

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2888%2980039-3

7 January 2021

Reduction of nigral glutamic acid decarboxylase in rats with neuroleptic-induced oral dyskinesia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2888%2980039-3

7 January 2021

Association with persistent neuroleptic-induced dyskinesia of regional changes in brain GABA synthesis

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2888%2980039-3

7 January 2021

Neurotoxic reactions resulting from chlorpromazine administration

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2888%2980039-3

7 January 2021

Characterization of [3H]cholecystokinin octapeptide binding to mouse brain synaptosomes: effects of neuroleptics

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2888%2980039-3

7 January 2021

The nullification by diazepam of haloperidol-induced increases in the level of striatal dopamine but not in the activity of glutamic acid decarboxylase

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2888%2980039-3

7 January 2021

Neuroleptic malignant syndrome: a pathogenetic role for dopamine receptor blockade?

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2888%2980039-3

7 January 2021

A subpopulation of mesencephalic dopamine neurons projecting to limbic areas contains a cholecystokinin-like peptide: evidence from immunohistochemistry combined with retrograde tracing

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2888%2980039-3

7 January 2021

Oral-buccal dyskinesia symptoms associated with low-dose benzodiazepine treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2888%2980039-3

7 January 2021

Preliminary evidence of reduced combined output of dopamine and its metabolites in chronic schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2888%2980039-3

7 January 2021

Noradrenergic and neuroradiological abnormalities in tardive dyskinesia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2888%2980039-3

7 January 2021

Treatment of tardive dyskinesia. I. Clinical efficacy of a dopamine-depleting agent, tetrabenazine

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2888%2980039-3

7 January 2021

Dopamine receptors in the central thermoregulatory mechanism of the cat

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2888%2980039-3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2888%2980039-3

7 January 2021

Neuroleptic malignant syndrome and amantadine withdrawal

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2888%2980039-3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2888%2980039-3

7 January 2021

Choline acetylase and glutamic acid decarboxylase in Huntington's chorea. A preliminary study

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2888%2980039-3

7 January 2021

Tetrabenazine for extra-pyramidal movement disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2888%2980039-3

7 January 2021

The pathophysiology of extrapyramidal side-effects of neuroleptic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2888%2980039-3

7 January 2021

Neuroleptic-induced oral dyskinesias: effects of progabide and lack of correlation with regional changes in glutamic acid decarboxylase and choline acetyltransferase activities

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2888%2980039-3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2888%2980039-3

7 January 2021

Cholecystokinin peptides, dopamine and schizophrenia--a review

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2888%2980039-3

7 January 2021

Current concepts. The malignant hyperthermia syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2888%2980039-3

7 January 2021

Localization of opiate receptors and enkephalins in the rat striatum in relationship with the nigrostriatal dopaminergic system: lesion studies

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2888%2980039-3

7 January 2021

Implications of Amphetamine-Induced Stereotyped Behavior as a Model for Tardive Dyskinesias

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2888%2980039-3

7 January 2021

Neuroleptic-opioid interaction: relevance to tardive dyskinesia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2888%2980039-3

7 January 2021

Successful treatment of neuroleptic-induced akathisia with baclofen and clonazepam. A case report

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2888%2980039-3

7 January 2021

Neuroleptic-induced hypersensitivity of striatal dopamine receptors in the rat as a model of tardive dyskinesias. Effects of clozapine, haloperidol, loxapine and chlorpromazine

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2888%2980039-3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2888%2980039-3

7 January 2021

Selective inhibition of mesolimbic behavioral supersensitivity by naloxone

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2888%2980039-3

7 January 2021

Dopamine receptors and the dopamine hypothesis of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2888%2980039-3

7 January 2021

Biologic and radioimmunologic activity of cholecystokinin in regions of mammalian brains

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2888%2980039-3

7 January 2021

Sustained improvement in tardive dyskinesia with diazepam: Indirect evidence for corticolimbic involvement

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2888%2980039-3

7 January 2021

Gamma-vinyl-GABA treatment of tardive dyskinesia and other movement disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2888%2980039-3

7 January 2021

Improvement in Tardive Dyskinesia After Muscimol Therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2888%2980039-3

7 January 2021

Oral Facial Dyskinesia Associated with Prolonged Use of Antihistaminic Decongestants

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2888%2980039-3

7 January 2021

New peptide in the vertebrate CNS reacting with antigastrin antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2888%2980039-3

7 January 2021

Endorphins in psychiatry: an overview and a hypothesis

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2888%2980039-3

7 January 2021

Tardive dyskinesia and cognitive impairment

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2888%2980039-3

7 January 2021

Choreic Movements Induced by the Use of Methadone

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2888%2980039-3

7 January 2021

Evidence for dopaminomimetic effect of intrastriatally injected cholecystokinin octapeptide in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2888%2980039-3

7 January 2021

Nicotine exposure and tardive dyskinesia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2888%2980039-3

7 January 2021

Antistereotypic effects of cholecystokinin octapeptide (CCK-8), ceruletide and related peptides on apomorphine-induced gnawing in sensitized mice

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2888%2980039-3

7 January 2021

Management of a case of neuroleptic malignant syndrome with bromocriptine

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2888%2980039-3

7 January 2021

10.1016/S0149-7634(88)80039-3

Identifiers

DOI

1 reference

12 September 2017

1 reference